Cargando…

Survival analysis over a 20-year period of a Brazilian cohort of blood donors coinfected HIV-HCV

Among individuals coinfected with HCV and HIV, studies of mortality from non-hepatic causes have shown inconsistent results. The aim of this study was to investigate the contribution of HCV and HIV co-infection to mortality from hepatic and non-hepatic causes in Brazil. This retrospective cohort stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Menezes Filho, Hélio Ranes, Grandi, Giuliano, Vaz Cardoso, Ludimila Paula, Galvão da Silva, Juan Felipe, Machado, Soraia Mafra, de Almeida-Neto, Cesar, Sabino, Ester Cerdeira, Mendes-Corrêa, Maria Cássia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590849/ https://www.ncbi.nlm.nih.gov/pubmed/37813358 http://dx.doi.org/10.1016/j.bjid.2023.102810

Ejemplares similares

Knowledge of Hepatitis C virus vertical transmission and subsequent pregnancy outcome in virus-positive female blood donors
por: Ranes de Menezes Filho, Hélio, et al.
Publicado: (2022)

Impact on mortality of being seropositive for hepatitis C virus antibodies among blood donors in Brazil: A twenty-year study
por: Filho, Hélio Ranes de Menezes, et al.
Publicado: (2019)

Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
por: Zuckerman, Autumn D., et al.
Publicado: (2019)

Managing HCV/HIV coinfection
por: Danish, Fazal A., et al.
Publicado: (2009)

Hepatitis C among blood donors: cascade of care and predictors of loss to follow-up
por: Machado, Soraia Mafra, et al.
Publicado: (2017)

HCV-HIV Chronic Coinfection Prevalence in Amazon Region
por: Lobo, Marcio Nahum, et al.
Publicado: (2022)

Evaluation of a High Throughput Method for the Detection of Mutations Associated with Thrombosis and Hereditary Hemochromatosis in Brazilian Blood Donors
por: Dionisio Tavares Niewiadonski, Vivian, et al.
Publicado: (2015)

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
por: de Gennaro, Nicolò, et al.
Publicado: (2020)

Erratum to “Barriers to treatment of hepatitis C in HIV/HCV coinfected adults in Brazil” [Braz. J. Infect. Dis. 14 (3) (2010) 237–241]
por: Mendes-Corrêa, Maria Cássia, et al.
Publicado: (2016)

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Therapeutic issues in HIV/HCV-coinfected patients
por: Sulkowski, M S, et al.
Publicado: (2007)

Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015)

Evidence for Implementation: HIV/HCV Coinfection and Pregnancy
por: Curtis, Megan Rose, et al.
Publicado: (2023)

Risk factors for deferral due to low hematocrit and iron depletion among prospective blood donors in a Brazilian center
por: Dauar, Eloísa Tedeschi, et al.
Publicado: (2015)

Complementary Role of HCV and HIV in T-Cell Activation and Exhaustion in HIV/HCV Coinfection
por: Feuth, Thijs, et al.
Publicado: (2013)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
por: Fanciulli, Chiara, et al.
Publicado: (2022)

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
por: Hatu, Giorgiana, et al.
Publicado: (2014)

Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
por: Mastroianni, Claudio M., et al.
Publicado: (2014)

Comorbidities and HCV coinfection in the management of HIV+ patients: evidence from the Italian clinical practice
por: Garagiola, Elisabetta, et al.
Publicado: (2020)

Epidemiological and clinical profile of HIV-infected patients from Southwestern Goias State, Brazil
por: Dias, Regyane Ferreira Guimarães, et al.
Publicado: (2018)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

Perinatal HCV Transmission Rate in HIV/HCV Coinfected women with access to ART in Madrid, Spain
por: Domínguez-Rodríguez, Sara, et al.
Publicado: (2020)

Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients
por: Fuster, Daniel, et al.
Publicado: (2021)

Monocyte Activation in HIV/HCV Coinfection Correlates with Cognitive Impairment
por: Rempel, Hans, et al.
Publicado: (2013)

HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation
por: Mavilia, Marianna G., et al.
Publicado: (2018)

Hepatitis C treatment initiation in HIV-HCV coinfected patients
por: Cotte, Laurent, et al.
Publicado: (2016)

Mathematical Modelling of HIV-HCV Coinfection Dynamics in Absence of Therapy
por: Mayanja, Edison, et al.
Publicado: (2020)

Prevalence of HCV and/or HBV coinfection in Iranian HIV-infected patients
por: Dehghani-Dehej, Farzaneh, et al.
Publicado: (2020)

Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany
por: Puglia, Monia, et al.
Publicado: (2015)

Cellular Activation and Intracellular HCV Load in Peripheral Blood Monocytes Isolated from HCV Monoinfected and HIV-HCV Coinfected Patients
por: Dichamp, Isabelle, et al.
Publicado: (2014)

Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China
por: Tan, Yi, et al.
Publicado: (2008)

Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis
por: Wu, Jingjing, et al.
Publicado: (2019)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Quality of life of the Brazilian speech therapist facing the covid-19 pandemic
por: Nasciutti Neto, Rubens, et al.
Publicado: (2022)

Efficacy and tolerability of telaprevir (TVR)-based triple therapy in HIV/HCV-coinfected patients
por: De Los Santos, Ignacio, et al.
Publicado: (2014)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
por: Vigón, Lorena, et al.
Publicado: (2019)

Population pharmacokinetic modeling of benznidazole in Brazilian patients with chronic Chagas disease
por: Frade, Virgínia Paula, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o8hk67l0sv6eo1n762gs8r4241